Folic acid-functionalized PEGylated niosomes co-encapsulated cisplatin and doxoribicin exhibit enhanced anticancer efficacy

Table 1 Desirability criteria and predicted values for the variable, DOX + CIS

Desirability	Lipid—µmoL	Sonication time—min	Surfactant: Cholesterol—molar ratio	Number
0.748	264.7	6.804	1.643	1

ISSN: 1868-6966